| http://www.w3.org/ns/prov#value | - CHESTERBROOK, Pa., Jan. 23, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company (Auxilium), today announced that it intends, subject to market and other conditions, to offer $200.0 million aggregate principal amount of Convertible Senior Notes due 2018 (the Convertible Notes") in an offering (the Offering) registered under the Securities A
|
